Cargando…
Chemotherapy in frail elderly patients with hormone-refractory prostate cancer: A “real world” experience
BACKGROUND: In elderly patients affected by metastatic castration-resistant prostate cancer (mCRPC) chemotherapic treatment may be the choice if one considers not only the chronological age, but also the clinical status, the functional reserve, and the vulnerability of patients. Several studies have...
Autores principales: | Tralongo, Paolo, Bordonaro, Sebastiano, Di Mari, Annamaria, Cappuccio, Francesco, Rametta Giuliano, Sebastiano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Pacific Prostate Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789324/ https://www.ncbi.nlm.nih.gov/pubmed/27014659 http://dx.doi.org/10.1016/j.prnil.2015.12.003 |
Ejemplares similares
-
Metformin and Cancer Treatment
por: Di Mari, Annamaria, et al.
Publicado: (2015) -
Psychological and sexual disorders in long-term breast cancer survivors
por: Pumo, Vitalinda, et al.
Publicado: (2012) -
Hematologic toxicity of radium-223 in elderly patients with metastatic Castration Resistant Prostate Cancer: a real-life experience
por: Costa, Renato P., et al.
Publicado: (2019) -
Clinicians’ and Patients’ Perceptions and Use of the Word “Cured” in Cancer Care: An Italian Survey
por: Tralongo, Paolo, et al.
Publicado: (2023) -
Active home-based cancer treatment
por: Bordonaro, Sebastiano, et al.
Publicado: (2012)